Literature DB >> 22252463

Reduced DICER1 elicits an interferon response in endometrial cancer cells.

Katherine B Chiappinelli1, Brian C Haynes, Michael R Brent, Paul J Goodfellow.   

Abstract

DICER1 is essential for the generation of mature miRNAs and other short noncoding RNAs. Several lines of investigation implicate DICER1 as a tumor suppressor. Reduced DICER1 levels and changes in miRNA abundance have been associated with aggressive tumor phenotypes. The global effects of reduced DICER1 on mRNA transcript abundance in tumor cells remain largely unknown. We used short hairpin RNA to stably knock down DICER1 in endometrial cancer cell lines to begin to determine how reduced DICER1 activity contributes to tumor phenotypes. DICER1 knockdown did not affect cell proliferation but caused enhanced cell migration and growth in soft agar. miRNA and mRNA profiling in KLE cells revealed overall decreases in miRNA levels and changes in the relative abundance of many mRNAs. One of the most striking changes in mRNA levels was the upregulation of IFN-stimulated genes (ISG), the majority of which lack known miRNA target sequences. IFNβ, a key upstream regulator of the IFN response, was significantly increased in DICER1 knockdowns in the AN3CA, Ishikawa, and KLE endometrial cancer cell lines and in the normal endometrial cell line EM-E6/E7/TERT. IFNβ secreted in media from KLE and EM-E6/E7/TERT shDcr cells was sufficient to activate an IFN response in HT29 cells. The reduced miRNA processing in DICER1 knockdowns was associated with increases in pre-miRNAs in the cytoplasm. Our findings suggest that elevated pre-miRNA levels trigger the IFN response to double-stranded RNA. We thus report a novel effect of reduced DICER1 function in cancer cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22252463      PMCID: PMC3307918          DOI: 10.1158/1541-7786.MCR-11-0520

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  50 in total

1.  Nuclear transcription of long hairpin RNA triggers innate immune responses.

Authors:  Michael P Gantier; John A Baugh; Seamas C Donnelly
Journal:  J Interferon Cytokine Res       Date:  2007-09       Impact factor: 2.607

2.  Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.

Authors:  Alireza Heravi-Moussavi; Michael S Anglesio; S-W Grace Cheng; Janine Senz; Winnie Yang; Leah Prentice; Anthony P Fejes; Christine Chow; Alicia Tone; Steve E Kalloger; Nancy Hamel; Andrew Roth; Gavin Ha; Adrian N C Wan; Sarah Maines-Bandiera; Clara Salamanca; Barbara Pasini; Blaise A Clarke; Anna F Lee; Cheng-Han Lee; Chengquan Zhao; Robert H Young; Samuel A Aparicio; Poul H B Sorensen; Michelle M M Woo; Niki Boyd; Steven J M Jones; Martin Hirst; Marco A Marra; Blake Gilks; Sohrab P Shah; William D Foulkes; Gregg B Morin; David G Huntsman
Journal:  N Engl J Med       Date:  2011-12-21       Impact factor: 91.245

3.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

4.  Dicer is involved in protection against influenza A virus infection.

Authors:  Alexey A Matskevich; Karin Moelling
Journal:  J Gen Virol       Date:  2007-10       Impact factor: 3.891

5.  Dicer, Drosha, and outcomes in patients with ovarian cancer.

Authors:  William M Merritt; Yvonne G Lin; Liz Y Han; Aparna A Kamat; Whitney A Spannuth; Rosemarie Schmandt; Diana Urbauer; Len A Pennacchio; Jan-Fang Cheng; Alpa M Nick; Michael T Deavers; Alexandra Mourad-Zeidan; Hua Wang; Peter Mueller; Marc E Lenburg; Joe W Gray; Samuel Mok; Michael J Birrer; Gabriel Lopez-Berestein; Robert L Coleman; Menashe Bar-Eli; Anil K Sood
Journal:  N Engl J Med       Date:  2008-12-18       Impact factor: 91.245

6.  Activation of the interferon system by short-interfering RNAs.

Authors:  Carol A Sledz; Michelle Holko; Michael J de Veer; Robert H Silverman; Bryan R G Williams
Journal:  Nat Cell Biol       Date:  2003-08-24       Impact factor: 28.824

Review 7.  Emerging strategies to strengthen the anti-tumour activity of type I interferons: overcoming survival pathways.

Authors:  M Caraglia; M Marra; P Tagliaferri; S W J Lamberts; S Zappavigna; G Misso; F Cavagnini; G Facchini; A Abbruzzese; L J Hofland; G Vitale
Journal:  Curr Cancer Drug Targets       Date:  2009-08-01       Impact factor: 3.428

8.  Suppression of non-small cell lung tumor development by the let-7 microRNA family.

Authors:  Madhu S Kumar; Stefan J Erkeland; Ryan E Pester; Cindy Y Chen; Margaret S Ebert; Phillip A Sharp; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-28       Impact factor: 11.205

9.  Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation.

Authors:  Sara A Byron; Michael G Gartside; Candice L Wellens; Mary A Mallon; Jack B Keenan; Matthew A Powell; Paul J Goodfellow; Pamela M Pollock
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

10.  Dicer is essential for mouse development.

Authors:  Emily Bernstein; Sang Yong Kim; Michelle A Carmell; Elizabeth P Murchison; Heather Alcorn; Mamie Z Li; Alea A Mills; Stephen J Elledge; Kathryn V Anderson; Gregory J Hannon
Journal:  Nat Genet       Date:  2003-10-05       Impact factor: 38.330

View more
  9 in total

1.  Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.

Authors:  Katherine B Chiappinelli; Pamela L Strissel; Alexis Desrichard; Huili Li; Christine Henke; Benjamin Akman; Alexander Hein; Neal S Rote; Leslie M Cope; Alexandra Snyder; Vladimir Makarov; Sadna Budhu; Sadna Buhu; Dennis J Slamon; Jedd D Wolchok; Drew M Pardoll; Matthias W Beckmann; Cynthia A Zahnow; Taha Merghoub; Taha Mergoub; Timothy A Chan; Stephen B Baylin; Reiner Strick
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

2.  ARF and p53 coordinate tumor suppression of an oncogenic IFN-β-STAT1-ISG15 signaling axis.

Authors:  Jason T Forys; Catherine E Kuzmicki; Anthony J Saporita; Crystal L Winkeler; Leonard B Maggi; Jason D Weber
Journal:  Cell Rep       Date:  2014-04-13       Impact factor: 9.423

3.  Effects of Sodium Butyrate Treatment on Histone Modifications and the Expression of Genes Related to Epigenetic Regulatory Mechanisms and Immune Response in European Sea Bass (Dicentrarchus Labrax) Fed a Plant-Based Diet.

Authors:  Genciana Terova; Noelia Díaz; Simona Rimoldi; Chiara Ceccotti; Emi Gliozheni; Francesc Piferrer
Journal:  PLoS One       Date:  2016-07-29       Impact factor: 3.240

4.  Dicer represses the interferon response and the double-stranded RNA-activated protein kinase pathway in mouse embryonic stem cells.

Authors:  Chandan Gurung; Mona Fendereski; Krishna Sapkota; Jason Guo; Faqing Huang; Yan-Lin Guo
Journal:  J Biol Chem       Date:  2021-01-08       Impact factor: 5.157

5.  Glycogen synthase kinase 3β inhibition as a therapeutic approach in the treatment of endometrial cancer.

Authors:  Yan Yin; Nora T Kizer; Premal H Thaker; Katherine B Chiappinelli; Kathryn M Trinkaus; Paul J Goodfellow; Liang Ma
Journal:  Int J Mol Sci       Date:  2013-08-12       Impact factor: 5.923

6.  Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers.

Authors:  Huili Li; Katherine B Chiappinelli; Angela A Guzzetta; Hariharan Easwaran; Ray-Whay Chiu Yen; Rajita Vatapalli; Michael J Topper; Jianjun Luo; Roisin M Connolly; Nilofer S Azad; Vered Stearns; Drew M Pardoll; Nancy Davidson; Peter A Jones; Dennis J Slamon; Stephen B Baylin; Cynthia A Zahnow; Nita Ahuja
Journal:  Oncotarget       Date:  2014-02-15

Review 7.  MicroRNAs: The Missing Link in the Biology of Graft-Versus-Host Disease?

Authors:  Sadaf Atarod; Anne Mary Dickinson
Journal:  Front Immunol       Date:  2013-12-02       Impact factor: 7.561

8.  Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors.

Authors:  Charles-André Philip; Ido Laskov; Marie-Claude Beauchamp; Maud Marques; Oreekha Amin; Joanna Bitharas; Roy Kessous; Liron Kogan; Tahira Baloch; Walter H Gotlieb; Amber Yasmeen
Journal:  BMC Cancer       Date:  2017-09-08       Impact factor: 4.430

Review 9.  DICER1: A Key Player in Rheumatoid Arthritis, at the Crossroads of Cellular Stress, Innate Immunity, and Chronic Inflammation in Aging.

Authors:  Aurore De Cauwer; Alexandre Mariotte; Jean Sibilia; Seiamak Bahram; Philippe Georgel
Journal:  Front Immunol       Date:  2018-07-24       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.